One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood-2021-147937
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 8 |
Affiliation: BC Cancer Agency, Jewish General Hospital, City of Hope, Seoul National University Hospital, Hospital Universitario La Paz, UPMC Hillman Cancer Center, University of Pennsylvania, Memorial Sloan Kettering Cancer Center, Princess Alexandra Hospital, University of Queensland, Royal Adelaide Hospital, Roche (China), Roche (Canada), Instituto de Investigación Biomédica de Salamanca, Washington University in St. Louis, Linear Clinical Research, Sir Charles Gairdner Hospital, St Vincent's Hospital, Royal North Shore HospitalSubcutaneous (SC) Administration of Mosunetuzumab with Cycle 1 Step-up Dosing Is Tolerable and Active in Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphomas (R/R B-NHL): Initial Results from a Phase I/II Study
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
